Posted on 22/10/03
IR's uphill battle
The last couple of years have been hard on investors -- and even tougher on investor relations professionals. Just ask Peter McBride, vice-president of investor relations at Theratechnologies Inc., a Montreal prescription drug development company.
The full text of this article has 1239 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
